# BBP (Virtus Biotech ETF)

not established · Thematic ETFs · data as of Sep 11, 2026

BBP holds 60 stocks, and 88% of its weight is outside the S&P 500.

## Key facts

- BBP, already in the S&P 500: 12.4%, as of Sep 11, 2026.
- BBP, active share vs the S&P 500: 99.0%, as of Sep 11, 2026.
- BBP, top ten holdings: 25.7%, as of Sep 11, 2026.
- BBP, total return, 1 year: +47.0%, as of Sep 11, 2026.
- BBP, net assets: $59m (SEC filing, whole fund, as filed for Apr 30, 2026).
- BBP, expense ratio: 0.34% (485BPOS XBRL, Feb 27, 2026).

## BBP over each window to Sep 11, 2026

| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
| --- | --- | --- | --- | --- |
| 3 months | +18.7% | +3.3% | +15.4 pts | +19.5 pts |
| 6 months | +27.3% | +16.0% | +11.3 pts | +6.7 pts |
| 1 year | +47.0% | +17.5% | +29.5 pts | +24.1 pts |
| 3 years | +94.7% | +77.9% | +16.8 pts | −0.4 pts |
| Since launch | +303.1% | +361.5% | −58.4 pts | −365.4 pts |

## Every published field

| Field | Value | Source |
| --- | --- | --- |
| Theme | Biotech and genomics | ETFIQ, editorial |
| Launched | Dec 17, 2014 | ETFIQ |
| Already in the S&P 500, by weight | 12.4% | ETFIQ |
| Active share vs the S&P 500 | 99.0% | ETFIQ |
| Already in the Nasdaq-100, by weight | 8.9% | ETFIQ |
| Active share vs the Nasdaq-100 | 97.4% | ETFIQ |
| Top ten holdings weight | 25.7% | ETFIQ |
| Holdings | 60 | ETFIQ |
| Holdings as of | Apr 30, 2026 | SEC N-PORT |
| Top holdings | IMMUNITYBIO INC 4.8%, APELLIS PHARMACEUTICALS INC 2.6%, KALVISTA PHARMACEUTICALS INC 2.5%, MODERNA INC 2.5%, IOVANCE BIOTHERAPEUTICS INC 2.5%, MIRUM PHARMACEUTICALS INC 2.4%, AXSOME THERAPEUTICS INC 2.2%, KINIKSA PHARMACEUTICALS INTERNATIONAL PLC 2.1%, ROIVANT SCIENCES LTD 2.1%, ZAI LAB LTD 1.9% | ETFIQ |
| Net assets | $59m | SEC filing, whole fund, as filed for Apr 30, 2026 |
| Below its all-time high | −5.9% | ETFIQ |
| Expense ratio | 0.34% | 485BPOS XBRL, Feb 27, 2026 |
| Fee for the part that differs from the S&P 500, active expense ratio | 0.34% | ETFIQ |
| Closest funds by holdings overlap | IBBQ 35%, PBE 34%, FBT 30%, WDNA 26%, HELX 24% | ETFIQ |

## Questions

### How much of BBP is in S&P 500 companies?

By its holdings filed for Apr 30, 2026, 12% of BBP by weight is stocks the S&P 500 already holds. Its active share against the index is 99%, so that share is the part doing something different.

### What does BBP hold?

60 positions as filed for Apr 30, 2026, with the top ten at 26% of the fund. The largest are IMMUNITYBIO INC at 4.8%, APELLIS PHARMACEUTICALS INC at 2.6%, KALVISTA PHARMACEUTICALS INC at 2.5%.

### Has BBP beaten the S&P 500?

Over the year to Sep 11, 2026 BBP returned +47.0% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 29.5 points.

### What does BBP cost?

The prospectus expense ratio is 0.34% a year. Because 99% of the fund differs from the S&P 500, the fee on that differing part works out at 0.34%.


## Cite this page

ETFIQ, BBP, data as of Sep 11, 2026. https://etfiq.com/funds/BBP
Free to use with attribution; the underlying files are at https://etfiq.com/data/.

HTML: https://etfiq.com/funds/BBP  ·  JSON: https://etfiq.com/funds/BBP.json